Pyrazole-Based Thrombin Inhibitors with a Serine-Trapping Mechanism of Action: Synthesis and Biological Activity

New antithrombotic drugs are needed to combat thrombosis, a dangerous pathology that causes myocardial infarction and ischemic stroke. In this respect, thrombin (FIIa) represents an important drug target. We herein report the synthesis and biological activity of a series of 1<i>H</i>-pyr...

Full description

Bibliographic Details
Published in:	Pharmaceuticals
Main Authors:	Calvin Dunker, Lukas Imberg, Alena I. Siutkina, Catharina Erbacher, Constantin G. Daniliuc, Uwe Karst, Dmitrii V. Kalinin
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Subjects:	covalent inhibitor thrombin thrombosis anticoagulants pyrazole Ullmann reaction
Online Access:	https://www.mdpi.com/1424-8247/15/11/1340

Similar Items

Thermodynamic, Anticoagulant, and Antiproliferative Properties of Thrombin Binding Aptamer Containing Novel UNA Derivative
by: Weronika Kotkowiak, et al.
Published: (2018-03-01)

Application of thrombin powder after tooth extraction in patients receiving anticoagulant therapy
by: Marjanović Marjan
Published: (2002-01-01)

Exploring potential anticoagulant drug formulations using thrombin generation test
by: Elena Zavyalova, et al.
Published: (2016-03-01)

Design strategy of antidote sequence for bivalent aptamer: Rapid neutralization of high‐anticoagulant thrombin‐binding bivalent DNA aptamer‐linked M08 with HD22
by: Toru Yoshitomi, et al.
Published: (2021-07-01)

Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram
by: Tuukka A. Helin, et al.
Published: (2021-03-01)

Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort
by: Tom W. van de Berg, et al.
Published: (2022-10-01)

A Review of On-Surface Synthesis and Characterization of Macrocycles
by: Chao Yan, et al.
Published: (2025-08-01)

The clinical usefulness of measuring thrombin generation
by: Coenraad H. Hemker
Published: (2023-03-01)

Ultrasound (US)-guided percutaneous thrombin injection for stoma-site bleeding after PEG tube insertion: a case series and review of the literature
by: Aws Alfahad, et al.
Published: (2024-02-01)

Thrombin generation to evaluate the complex hemostatic balance of hemophilia A plasma containing direct oral anticoagulant and supplemented by factor VIII
by: Sylvain Lamoine, et al.
Published: (2024-10-01)

Exploring the Interaction of Pyridine-Based Chalcones with Trinuclear Silver(I) Pyrazolate Complex
by: Arina Olbrykh, et al.
Published: (2023-04-01)

The Regioselective Conjugation of the 15-nt Thrombin Aptamer with an Optimized Tripeptide Sequence Greatly Increases the Anticoagulant Activity of the Aptamer
by: Irina V. Varizhuk, et al.
Published: (2023-02-01)

Reference values for thrombin dynamics in platelet rich plasma
by: Qiuting Yan, et al.
Published: (2021-02-01)

Inhibition of thrombin generation 12 hours after intake of direct oral anticoagulants
by: Michael Metze, et al.
Published: (2020-05-01)

Flavonol and A-type procyanidin-rich extracts of Prunus spinosa L. flower exhibit anticoagulant activity through direct thrombin inhibition, but do not affect platelet aggregation in vitro
by: Anna Marchelak, et al.
Published: (2023-11-01)

Percutaneous thrombin injection for pseudoaneurysm treatment
by: Gareth Bydawell
Published: (2013-03-01)

Thrombin-induced platelet aggregation −effect of dabigatran using automated platelet aggregometry−
by: Mie Shimizu, et al.
Published: (2020-04-01)

Screening of the Promising Direct Thrombin Inhibitors from Haematophagous Organisms. Part I: Recombinant Analogues and Their Antithrombotic Activity In Vitro
by: Maria A. Kostromina, et al.
Published: (2021-12-01)

Purification and characterization of thrombin from camel plasma: interaction with camel tick salivary gland thrombin inhibitor
by: Mahmoud A. Ibrahim, et al.
Published: (2023-01-01)

A Comprehensive Analysis of the Thrombin Binding Aptamer Containing Functionalized Pyrrolo-2’-deoxycytidines
by: Weronika Kotkowiak, et al.
Published: (2021-12-01)

Plasma thrombin generation in the presence of TIX-5 may contribute significantly to a prediction model for major bleeding in patients on VKA anticoagulant therapy
by: Anja Sol-Maag, et al.
Published: (2024-06-01)

Paralogism in the interpretation of thrombogram obtained with the thrombin generation assay of human blood plasma
by: Ye. M. Makogonenko, et al.
Published: (2025-02-01)

Age- and sex-dependency of thrombin generation parameters in the general Italian population: the Moli-sani study
by: Simona Costanzo, et al.
Published: (2025-02-01)

Determining Thrombogenicity: Using a Modified Thrombin Generation Assay to Detect the Level of Thrombotic Event Risk in Lupus Anticoagulant-Positive Patients
by: Pavla Bradáčová, et al.
Published: (2023-12-01)

Ultrasound-guided percutaneous periarterial thrombin injection for paracentesis-related hemoperitoneum
by: Boya Abudu, BS, et al.
Published: (2018-02-01)

Advancing EGFR-targeted anticancer strategies: the potential of thiazole, pyrazole, and thiazole–pyrazole hybrids
by: Prerana Sanas, et al.
Published: (2025-10-01)

PATIENTS REFERRED FOR BLEEDING SYMPTOMS OF UNKNOWN CAUSE: DOES EVALUATION OF THROMBIN GENERATION CONTRIBUTE TO DIAGNOSIS?
by: Elena Holm, et al.
Published: (2016-02-01)

Synthesis of Perfluoroalkylated Pyrazoles from α-Perfluoroalkenylated Aldehydes
by: Lennart Bunnemann, et al.
Published: (2024-10-01)

Rapid Determination of Xa Inhibitor Activity in Blood Using a Microfluidic Device that Measures Platelet Deposition and Fibrin Generation Under Flow
by: Jason M. Rossi, et al.
Published: (2025-01-01)

Direct oral anticoagulants in cirrhosis: Rationale and current evidenceKeypoints
by: Cindy Pereira Portela, et al.
Published: (2024-08-01)

Novel strategies in antithrombotic therapy: targeting thrombosis while preserving hemostasis
by: Martha M. S. Sim, et al.
Published: (2023-10-01)

Effects of direct oral anticoagulants dabigatran and rivaroxaban on the blood coagulation function in rabbits
by: Yin Lu, et al.
Published: (2022-01-01)

Expanding the recognition interface of the thrombin-binding aptamer HD1 through modification of residues T3 and T12
by: Igor Smirnov, et al.
Published: (2021-03-01)

Management of Visceral Artery Pseudoaneurysms by Combined Technique of Percutaneous Thrombin Injection and Endovascular Coiling
by: Kalpana Sivalingam, et al.
Published: (2021-06-01)

Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients
by: A. B. Sumarokov, et al.
Published: (2020-03-01)

Effect of Thrombin on the Metabolism and Function of Murine Macrophages
by: Ürün Ukan, et al.
Published: (2022-05-01)

New Series of Pyrazoles and Imidazo-Pyrazoles Targeting Different Cancer and Inflammation Pathways
by: Maria Grazia Signorello, et al.
Published: (2021-09-01)

A One-Pot Divergent Sequence to Pyrazole and Quinoline Derivatives
by: Guido Gambacorta, et al.
Published: (2020-05-01)

An Improved Synthesis Process of Ricolinostat: The First Orally Selective HDAC6 Inhibitor
by: Mengfei Wang, et al.
Published: (2024-12-01)

Synthesis of N3-substituted-quinazoline-2,4(1H,3H)-diones via CuI-catalyzed coupling of 2-iodobenzamides with potassium cyanate
by: Ali Nasirpour, et al.
Published: (2025-05-01)